Instylla Inc.August 1, 2022Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models
PanTher TherapeuticsMay 31, 2022PanTher Therapeutics Secures Patent for Anticancer Drug-Eluting Stent
Sera PrognosticsMay 20, 2022Sera Prognostics Presents Data Demonstrating the Health & Economic Benefit of PRETRM® Testing at Ispor Annual Meeting
Sera PrognosticsMay 5, 2022Sera Prognostics and Newborn Foundation Partner to Reduce Risks Associated with Preterm Birth and Improve Health Equity Through the “Every Mother, Every Baby” Project
AtaCor MedicalApril 29, 2022AtaCor Medical to Present Preliminary Results from First-in-Human Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study
Sera PrognosticsMarch 18, 2022Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting
AviveMarch 16, 2022Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest
EpitelFebruary 16, 2022Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System
AtaCor MedicalDecember 20, 2021AtaCor Medical Completes Enrollment in its Initial Acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study
